Top
  • Company
    • Overview
    • Leadership
    • Board of Directors
    • Contact Us
  • Science
    • ST266 Biologic
    • Key Mechanisms to Healing
    • Innovative Delivery Options
    • Scalable Manufacturing
    • Scientific Publications
  • Pipeline
    • Current Programs
    • Other Programs
    • Clinical Trials
  • News
    • Press Releases
  • Careers
    • Why Noveome?
    • Hear From Our Employees
    • Pittsburgh Please
    • Competitive Benefits
    • Career Opportunities
  • Company
    • Overview
    • Leadership
    • Board of Directors
    • Contact Us
  • Science
    • ST266 Biologic
    • Key Mechanisms to Healing
    • Innovative Delivery Options
    • Scalable Manufacturing
    • Scientific Publications
  • Pipeline
    • Current Programs
    • Other Programs
    • Clinical Trials
  • News
    • Press Releases
  • Careers
    • Why Noveome?
    • Hear From Our Employees
    • Pittsburgh Please
    • Competitive Benefits
    • Career Opportunities

Category: Publication

Topical Application of ST266 reduces UV-induced skin damage

Posted on November 10, 2017April 21, 2020 by admin

Guan, L., et al.

Continue reading “Topical Application of ST266 reduces UV-induced skin damage” →

Posted in Publication

Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model

Posted on January 31, 2017February 6, 2020 by admin

Khan, R.S., et al.

Continue reading “Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model” →

Posted in Publication

Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of penetrating ballistic-like brain injury

Posted on November 5, 2015 by admin

Deng-Bryant Y., et al.

Continue reading “Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of penetrating ballistic-like brain injury” →

Posted in Publication

Safety profile of Amnion-derived Cellular Cytokine Solution (ACCS) following topical skin application in patients receiving breast radiotherapy

Posted on July 28, 2015 by admin

Trombetta, M., et al.,

Continue reading “Safety profile of Amnion-derived Cellular Cytokine Solution (ACCS) following topical skin application in patients receiving breast radiotherapy” →

Posted in Publication

Amnion-derived multipotent cells inhibit blood monocyte differentiation into mature dendritic cells

Posted on September 5, 2014October 3, 2019 by admin

Banas, R.A., et al.,

Continue reading “Amnion-derived multipotent cells inhibit blood monocyte differentiation into mature dendritic cells” →

Posted in Publication

Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats

Posted on August 4, 2014October 3, 2019 by admin

Kueckelhaus, M., et al.,

Continue reading “Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats” →

Posted in Publication

Amnion-derived multipotent progenitor cells improve achilles tendon repair in rats.

Posted on June 19, 2013October 3, 2019 by admin

Philip, J., et al.,

Continue reading “Amnion-derived multipotent progenitor cells improve achilles tendon repair in rats.” →

Posted in Publication

Amnion-derived multipotent progenitor cells support allograft tolerance induction.

Posted on June 13, 2013October 3, 2019 by admin

Anam, K., et al.,

Continue reading “Amnion-derived multipotent progenitor cells support allograft tolerance induction.” →

Posted in Publication

Long-term administration of amnion-derived cellular cytokine suspension promotes functional recovery in a model of penetrating ballistic-like brain injury

Posted on August 7, 2012October 3, 2019 by admin

Deng-Bryant, Y., et al.,

Continue reading “Long-term administration of amnion-derived cellular cytokine suspension promotes functional recovery in a model of penetrating ballistic-like brain injury” →

Posted in Publication

Individualized, targeted wound treatment based on the tissue bacterial level as a biological marker

Posted on August 20, 2011October 3, 2019 by admin

Pierpont, Y.N., et al.,

Continue reading “Individualized, targeted wound treatment based on the tissue bacterial level as a biological marker” →

Posted in Publication

Posts navigation

Older posts
Newer posts

Recent Posts

  • Noveome Biotherapeutics, Inc. Announces Issuance of U.S. Patent No. 12,121,546 Entitled, “Treatment of Systemic Inflammatory Responses”
  • Noveome Biotherapeutics, Inc. Announces Completion of Treatment of the First Baby in its Phase 1-2 Clinical Trial Evaluating ST266 in the Treatment of Necrotizing Enterocolitis in Premature Infants
  • The novel secretome ST266 activates Akt and protects against oxidative stress-mediated injury in human RPE and Müller cells
  • Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
  • Noveome Biotherapeutics, Inc. Completes First Close of $40 Million Series E Financing to Support Clinical Trials in NEC

Recent Comments

    Archives

    • November 2024
    • July 2024
    • December 2023
    • August 2023
    • June 2023
    • November 2022
    • July 2022
    • May 2022
    • January 2022
    • June 2021
    • May 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • October 2019
    • September 2019
    • June 2019
    • May 2019
    • April 2019
    • May 2018
    • April 2018
    • January 2018
    • November 2017
    • January 2017
    • November 2015
    • July 2015
    • September 2014
    • August 2014
    • June 2013
    • August 2012
    • August 2011
    • May 2011
    • January 2011
    • July 2010
    • May 2010
    • November 2009
    • October 2009
    • March 2009
    • June 2008
    • April 2008
    • October 2007

    Categories

    • Board of Directors
    • Management
    • Press Release
    • Publication
    • Scientific Advisory Board

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    contact

    +1.412.402.9914

    General inquiries: info@noveome.com

    Clinical inquiries: clinical@noveome.com

    Noveome Biotherapeutics, Inc.

    620 Alpha Drive

    Suite 2

    Pittsburgh, PA 15238

    • Company
    • Science
    • Pipeline
    • News
    • Careers

    privacy policy

    terms of use

    © 2020 Noveome Biotherapeutics, Inc. All rights reserved. Noveome® is a registered trademark of Noveome Biotherapeutics, Inc.